Medical Properties (NYSE:MPW) hit a new 52-week high Tuesday as it is currently trading at $17.08, above its previous 52-week high of $17.02 with 167,014 shares traded as of 10:46 a.m. ET. Average volume has been 2.1 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Medical Properties (NYSE: MPW) hit a new 52-week high Tuesday as it is currently trading at $17.08, above its previous 52-week high of $17.02 with 167,014 shares traded as of 10:46 a.m. ET. Average volume has been 2.1 million shares over the past 30 days. Medical has a market cap of $2.51 billion and is part of the financial sector and real estate industry. Shares are up 41.1% year to date as of the close of trading on Monday. Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The company has a P/E ratio of 24.6, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Medical Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.